Evidence map›Paper›PMID 39939989›Full record

ArticleMalaria journal2025

Where is the hard-to-reach population? Spatial analysis from a cross-sectional study on the access to bed net and malaria vaccine in the Lake Victoria Region, Kenya.

Yura K Ko, Wataru Kagaya, Daisuke Yoneoka, James Kongere, Victor Opiyo, Jared Oginga, Protus Omondi, Kelvin B Musyoka, Chim W Chan, Bernard N Kanoi and 2 more

Abstract read
In one paragraph

Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yura K KoDepartment of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Solna, Sweden. yurako0603@gmail.com.
Wataru KagayaDepartment of Ecoepidemiology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
Daisuke YoneokaCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
James KongereDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Victor OpiyoCenter for Research in Tropical Medicine and Community Development, Nairobi, Kenya.
Jared OgingaCenter for Research in Tropical Medicine and Community Development, Nairobi, Kenya.
Protus OmondiDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Kelvin B MusyokaDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Chim W ChanDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Bernard N KanoiCenter for Research in Infectious Diseases, Directorate of Research and Innovation, Mount Kenya University, Thika, Kenya.
Jesse GitakaCenter for Research in Infectious Diseases, Directorate of Research and Innovation, Mount Kenya University, Thika, Kenya.
Akira KanekoDepartment of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Solna, Sweden.

Funding

JICA/AMED 20JM0110020H0002
6 · The paper itself

Abstract

backgroundLong-lasting insecticidal nets (LLIN) and vaccines are effective malaria control tools. However, inadequate uptake has been reported in countries where both interventions are available. To maximize the impact these tools provide, it is crucial to identify populations that are not being reached and the barriers to uptake.

methodsIn a cross-sectional study conducted in April 2024 in Kanyamwa Kologi Ward in Homa Bay County, Kenya, 4,662 households in 58 randomely selected villages were visited and interviewed. The proportions of households that (1) received at least one new LLIN within the previous five months (net distribution), (2) reported all children used LLIN (net usage), (3) reported at least one child had received one dose of the RTS,S vaccine (vaccine uptake), and (4) reported all children had received four doses of the vaccine (vaccine completion) were examined. Bayesian spatial autoregression analyses were used to estimate adjusted odds ratio (aOR) and its credible intervals (CrI) to identify the association between the household-level characteristics and the four outcomes.

resultsThe overall uptake proportions were 89.9% for net distribution, 84.4% for net usage, 88.2% for vaccine uptake, and 53.7% for vaccine completion. All four outcomes showed geographical heterogeneity with significant (p < 0.05) Moran's I. Households headed by adults of > 40 years had higher odds of having received a new LLIN (aOR = 2.02, 95% CrI 1.02-5.42), having one child who had received one vaccine dose (aOR = 1.83, 0.69-4.66), and having all children fully vaccinated (aOR = 2.36, 1.09-5.46), but lower odds of net usage by all children (aOR = 0.62, 0.40-0.96). Households with five or more children had higher odds of having received a new LLIN (aOR = 5.36, 2.24-27.0) but lower odds of net usage by all children (aOR = 0.24, 0.14-0.38) and having all children fully vaccinated (aOR = 0.20, 0.04-0.61). Distance to the nearest health centre was negatively associated with all outcomes. Household wealth was positively associated with all outcomes.

conclusionUptake of LLIN and malaria vaccine in Homa Bay County, Kenya varied by geography and household characteristics. These findings suggest that different sets of actions should be considered to improve the coverage and compliance of these interventions in different areas.

Indexed as

Insecticide-Treated BednetsMalariaMalaria VaccinesMosquito ControlAdolescentAdultChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantKenyaMaleMiddle AgedSpatial AnalysisMalaria VaccinesAccessKenyaLLINMalaria vaccineMass net distributionRTS,SSpatial analysisVaccine uptake

Identifiers

PMID39939989
PMCPMC11823133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.